Open-Angle Glaucoma
Conditions
Interventions
MLT Treatment Group:MLT therapy
Pharmacotherapy Control Group:Intraocular pressure-lowering drug therapy
Sponsors
Affiliated Jinhua Hospital, Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Primary open-angle glaucoma; 2) Normal-tension glaucoma; 3) Ocular hypertension; 4) Secondary open-angle glaucoma, such as elevated intraocular pressure following vitrectomy or steroid-induced glaucoma; 5) Patients voluntarily underwent micropulse laser trabeculoplasty and provided written informed consent.
Exclusion criteria
Exclusion criteria: 1) Presence of angle closure or angle recession in any quadrant; 2) Individuals with corneal pathologies or scarring; 3) Subjects presenting with ocular inflammation; 4) Cases exhibiting neovascularization of the angle; 5) Patients accompanied by severe systemic diseases; 6) Those with a history of prior anti-glaucoma surgical or laser interventions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eyesight;Intraocular pressure;Corneal endothelial cell count;Visual field;Optic disc nerve fiber layer thickness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complication;Utilize several intraocular pressure-lowering medications; | — |
Countries
China
Contacts
Public ContactPeiling Xie
Affiliated Jinhua Hospital, Zhejiang University School of Medicine
Outcome results
None listed